Download
1 / 4
40 likes | 42 Views
The global Molecular cytogenetics market will grow at a CAGR of 11% from 2017 to 2022 to reach USD 2,266.4 million by 2022, according to this latest publication from Meticulous Researchu00ae. The molecular cytogenetics market is driven by increasing focus on preventive healthcare measures, growing genetic abnormalities, increasing aging population and subsequent rise in various chronic diseases, growing need to reduce mounting healthcare cost, and increasing focus on clinical and research diagnosis. Moreover, increasing focus on targeted based therapies and growing predictive and presymptomatic genetic testing further provides significant opportunities in this market. However, lack of awareness about diagnostic technologies, the high cost of diagnosis, and unfavorable reimbursement scenario within the molecular cytogenetics, and technical limitations and complexities of the equipment have embraced the growth of molecular cytogenetic market globally. While the transition from fluorescence in situ hybridization to array based techniques is one of the notable trends observed in the global molecular cytogenetics market.
E N D
Molecular Cytogenetics Market 2017- 2022 Molecular Cytogenetics Market Worth USD 2,266.4 Million By 2022 says Meticulous research The global Molecular cytogenetics market will grow at a CAGR of 11% from 2017 to 2022 to reach USD 2,266.4 million by 2022, according to this latest publication from Meticulous Research®. The molecular cytogenetics market is driven by increasing focus on preventive healthcare measures, growing genetic abnormalities, increasing aging population and subsequent rise in various chronic diseases, growing need to reduce mounting healthcare cost, and increasing focus on clinical and research diagnosis. Moreover, increasing focus on targeted based therapies and growing predictive and presymptomatic genetic testing further provides significant opportunities in this market. However, lack of awareness about diagnostic technologies, the high cost of diagnosis, and unfavorable reimbursement scenario within the molecular cytogenetics, and technical limitations and complexities of the equipment have embraced the growth of molecular cytogenetic market globally. While the transition from fluorescence in situ hybridization to array based techniques is one of the notable trends observed in the global molecular cytogenetics market. Get Free Sample Copy of This Report at: https://www.meticulousresearch.com/request-sample-report/cp_id=3067 Market Segmentation The global molecular cytogenetics market is mainly segmented by technique (fluorescence in situ hybridization, comparative genomic hybridization, in situ hybridization, karyotyping, and banding techniques), by product (instruments, kits and reagents, software, services, and consumable/accessories ), by application (oncology, genetic disorders, personalized medicines, and other), and by end user (pharmaceuticals and biotechnological companies, clinical and diagnostic laboratories, and academic institutes). The comparative genome hybridization is further classified into an array based CGH and matrix based CGH, whereas, the karyotyping market is further segmented into Spectral Karyotyping and virtual karyotyping. Banding techniques are further classified into G banding, R banding, C banding, Q banding, and T banding. The comparative genomic hybridization technology segment commanded the largest share of the global molecular cytogenetics market and is expected to grow at the fastest CAGR in the next five years mainly due to the growing adoption of array CGH for various applications. Follow Us On:
Molecular Cytogenetics Market 2017- 2022 Geographic Overview Geographically, the global molecular cytogenetics market is segmented into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. North America accounted for the major share in the global molecular cytogenetics market in 2016, followed by Europe, and Asia-Pacific region. The large share of this region is primarily attributed to the increased funding for medical research, stringent drug development regulations which demand molecular cytogenetics techniques, growing aging population and thereby prevalence of various chronic diseases, and direct & indirect financial investments in the pharma biotech companies. However, Asia-Pacific region possesses lucrative growth potential for the molecular cytogenetic market during the forecast period owing to the increasing demand in China and India, growing population, various technological advancements, growing investment from government & non- government bodies, and growing pharma biotech industry in the region. Key Players The leading companies have employed various strategies to expand their product and application offerings, global footprint, and augment their market share. The key strategies followed by most companies in the global molecular cytogenetics market were new product developments, acquisitions, and expansions. The key players in the global molecular cytogenetics market are Thermo Fisher Scientific, Abbott Laboratories, Agilent Technologies, PerkinElmer, Bio-Rad Laboratories, Applied Spectral Imaging, Quest Diagnostics, Roche Diagnostics, Danaher Corporation, Illumina, and Oxford Gene Technology. Browse in-depth Report with TOC at: https://www.meticulousresearch.com/product/molecular-cytogenetics- market/ Scope of Molecular Cytogenetics Market report Market by Techniques: •Fluorescence In Situ Hybridization •Comparative Genomic Hybridization (CGH) oChromosomal CGH oArray-Based CGH •In Situ Hybridization Follow Us On:
Molecular Cytogenetics Market 2017- 2022 •Karyotyping oSpectral Karyotyping oVirtual Karyotyping •Banding Techniques oG banding oQ banding oR banding oC banding oT banding Market by Product: •Instruments oSystems oImagers and Scanners •Kits and Reagents oTesting Kits oProbes oReagents •Software •Services •Consumables/Accessories Market by Application: •Oncology •Genetic Disorders •Personalized Medicines •Others Market by End Users: •Pharmaceutical and Biotechnological companies •Clinical and Diagnostic laboratories Continued… Follow Us On:
Molecular Cytogenetics Market 2017- 2022 About Us: The name of our company defines our services, strengths, and values. Since the inception, we have endeavoured to research, analyze and present the critical market data with great attention to details. Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Khushal Meticulous Research® Contact Sales- +1-646-781-8004 Email: sales@meticulousresearch.com Website: https://www.meticulousresearch.com Browse Our Blog: https://globalmarketstudy.blogspot.com/ Find us on: | LinkedIn | Twitter | Follow Us On:
